These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 32475041)
1. Potential role of anti-interleukin-17 in COVID-19 treatment. Ayhan E; Öztürk M; An İ; Abdelmaksoud A; Araç E Dermatol Ther; 2020 Jul; 33(4):e13715. PubMed ID: 32475041 [No Abstract] [Full Text] [Related]
2. May IL-17 have a role in COVID-19 infection? Megna M; Napolitano M; Fabbrocini G Med Hypotheses; 2020 Jul; 140():109749. PubMed ID: 32339777 [No Abstract] [Full Text] [Related]
3. Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome? Casillo GM; Mansour AA; Raucci F; Saviano A; Mascolo N; Iqbal AJ; Maione F Pharmacol Res; 2020 Jun; 156():104791. PubMed ID: 32302707 [TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19? Nicolau DV; Bafadhel M Lancet Respir Med; 2020 Sep; 8(9):846-847. PubMed ID: 32738928 [No Abstract] [Full Text] [Related]
6. Vascular microthrombosis associated with increased interleukin-6. A severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab. Mohebbi N; Abedini A; Lashgari R; Razavi F; Varahram M; Kiani A Adv Respir Med; 2020; 88(5):468-469. PubMed ID: 33169824 [No Abstract] [Full Text] [Related]
7. Ivermectin: potential candidate for the treatment of Covid 19. Gupta D; Sahoo AK; Singh A Braz J Infect Dis; 2020; 24(4):369-371. PubMed ID: 32615072 [No Abstract] [Full Text] [Related]
8. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale. Schluger NW Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059 [TBL] [Abstract][Full Text] [Related]
9. Misguided drug advice for COVID-19. FitzGerald GA Science; 2020 Mar; 367(6485):1434. PubMed ID: 32198292 [No Abstract] [Full Text] [Related]
10. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Zhang T; He Y; Xu W; Ma A; Yang Y; Xu KF Sci China Life Sci; 2020 May; 63(5):774-776. PubMed ID: 32124179 [No Abstract] [Full Text] [Related]
12. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336 [No Abstract] [Full Text] [Related]
13. Chloroquine for COVID-19 Infection. Moore N Drug Saf; 2020 May; 43(5):393-394. PubMed ID: 32266694 [No Abstract] [Full Text] [Related]
14. COVID-19: Pentoxifylline as a potential adjuvant treatment. Feily A; Daneshpay K; Alighadr A Int J Clin Pharmacol Ther; 2020 Jul; 58(7):406-407. PubMed ID: 32449676 [No Abstract] [Full Text] [Related]
15. [Thinking on clinical rational use of TCM injection in the treatment of novel coronavirus pneumonia (COVID-19)]. Wang ZF; Wang YP; Zhang HM; Fan YP; Lü C; Wang YY Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(14):1044-1047. PubMed ID: 32294864 [TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquin for COVID-19 Why was so much hype? Pahlajani D J Assoc Physicians India; 2020 Aug; 68(8):94-96. PubMed ID: 32738852 [No Abstract] [Full Text] [Related]
18. COVID-19 and vitamin D-Is there a link and an opportunity for intervention? Jakovac H Am J Physiol Endocrinol Metab; 2020 May; 318(5):E589. PubMed ID: 32297519 [No Abstract] [Full Text] [Related]
19. Thalidomide Should Be Tested as a Therapeutic Option in COVID-19 Pneumonia. Tiscornia JE; Poggio TV; Feinsilber DG; Coleman AE Skinmed; 2020; 18(4):254-255. PubMed ID: 33050993 [No Abstract] [Full Text] [Related]
20. Immunomodulators in COVID-19: Two Sides to Every Coin. Snow TAC; Singer M; Arulkumaran N Am J Respir Crit Care Med; 2020 Nov; 202(10):1460-1462. PubMed ID: 32926809 [No Abstract] [Full Text] [Related] [Next] [New Search]